The Biologics News and Reports Portal

Show Cart

Target Pipelines

Results 1 - 10 of 67

May 2022 Cadherin 17: A target opportunity to develop effector-enhanced drug modalities

400.00 €

May 2022 Claudin 6: A target opportunity to develop effector-enhanced drug modalities

500.00 €

Dec 2018 Interleukin-33/Receptor Targeted Antibodies – Target Pipeline List 12/2018

75.00 €

Nov 2018 Neulasta Biosimilars – Target Pipeline List 11/2018

150.00 €

Nov 2018 Avastin Biosimilars - Target Pipeline List 11/2018

150.00 €

Nov 2018 MerTK Inhibitors – Target Pipeline List 11/2018

100.00 €

Nov 2018 Humira Biosimilars – Target Pipeline List 11/2018

150.00 €

Start
Prev
1
2
3
4
5
6
7
Next
End

Shopping cart

Cart empty

Latest report

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

Featured Products

2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Latest Target Pipeline

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Shopping cart

Cart empty

Latest report

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

Featured Products

2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Latest Target Pipeline

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Target Pipelines

May 2022 Cadherin 17: A target opportunity to develop effector-enhanced drug modalities

May 2022 Claudin 6: A target opportunity to develop effector-enhanced drug modalities

Apr 2020 STING Agonists & Antagonists – Target Pipeline List 04/2020

Feb 2020 TIGIT-Targeted Immunotherapeutics – Target Pipeline List 02/2020

Dec 2018 TFPI Inhibitors – Target Pipeline List

Dec 2018 Interleukin-33/Receptor Targeted Antibodies – Target Pipeline List 12/2018

Nov 2018 Neulasta Biosimilars – Target Pipeline List 11/2018

Nov 2018 Avastin Biosimilars - Target Pipeline List 11/2018

Nov 2018 MerTK Inhibitors – Target Pipeline List 11/2018

Nov 2018 Humira Biosimilars – Target Pipeline List 11/2018

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing